Chemotherapy for bladder cancer with neocarzinostatin: Evaluation of systemic administration
- 31 December 1979
- journal article
- research article
- Published by Elsevier
- Vol. 16 (1) , 103-113
- https://doi.org/10.1016/0014-2964(80)90115-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cellsCellular and Molecular Life Sciences, 1979
- Mechanism of Accumulation of the Antitumor Protein Antibiotic Neocarzinostatin in Bladder Tissue: Intravenous Administration, Urinary Excretion, and Absorption into Bladder TissueAntimicrobial Agents and Chemotherapy, 1977
- Fate and distribution of [14C] succinyl neocarzinostatin in ratsPublished by Elsevier ,1976
- Specific G2 block in HeLa-S3 cells by neocarzinostatinPublished by Elsevier ,1975
- Different drugs arrest cells at a number of distinct stages in G2Nature, 1975
- Concepts for systemic treatment of micrometastasesCancer, 1975
- Structure of the antitumor protein neocarzinostatinArchives of Biochemistry and Biophysics, 1974
- Clinical Trials of a New Antitumor Polypeptide: Neocarzinostatin (NCS)The Tohoku Journal of Experimental Medicine, 1969
- THIOTEPA IN THE TREATMENT OF TUMOURS OF THE BLADDERThe Lancet, 1961
- EPITHELIOMA OF THE GENITO-URINARY ORGANSAnnals of Surgery, 1922